Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR)
India flag India · Delayed Price · Currency is INR
4,905.70
+0.60 (0.01%)
At close: May 13, 2025, 3:30 PM IST

NSE:SANOFICONR Income Statement

Millions INR. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023
Period Ending
Mar '25 Dec '24 Dec '23
Revenue
6,7557,2458,331
Revenue Growth (YoY)
--13.04%-
Cost of Revenue
1,6651,8772,291
Gross Profit
5,0905,3686,041
Selling, General & Admin
1,3021,2351,050
Other Operating Expenses
1,2601,4271,709
Operating Expenses
2,6182,7072,786
Operating Income
2,4722,6613,255
Interest Expense
-43-39-
Interest & Investment Income
11811860
Currency Exchange Gain (Loss)
11-
Other Non Operating Income (Expenses)
33111.5
EBT Excluding Unusual Items
2,5812,7523,317
Asset Writedown
-29-29-
Other Unusual Items
-255-255-27
Pretax Income
2,2972,4683,290
Income Tax Expense
614658816
Net Income
1,6831,8102,474
Net Income to Common
1,6831,8102,474
Net Income Growth
--26.82%-
Shares Outstanding (Basic)
212323
Shares Outstanding (Diluted)
212323
EPS (Basic)
81.5078.59107.40
EPS (Diluted)
81.5078.59107.40
EPS Growth
--26.82%-
Free Cash Flow
-4,291-66
Free Cash Flow Per Share
-186.32-2.87
Dividend Per Share
-55.000-
Gross Margin
75.35%74.09%72.51%
Operating Margin
36.59%36.73%39.07%
Profit Margin
24.92%24.98%29.69%
Free Cash Flow Margin
-59.23%-0.79%
EBITDA
2,4932,6833,282
EBITDA Margin
36.90%37.03%39.40%
D&A For EBITDA
20.752227
EBIT
2,4722,6613,255
EBIT Margin
36.59%36.73%39.07%
Effective Tax Rate
26.73%26.66%24.81%
Revenue as Reported
6,9077,3758,393
Advertising Expenses
-181-
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.